• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDM2表达作为透明细胞肾细胞癌的预后指标:与p53过表达及临床病理参数的比较

mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters.

作者信息

Haitel A, Wiener H G, Baethge U, Marberger M, Susani M

机构信息

Department of Pathology, University of Vienna, Austria.

出版信息

Clin Cancer Res. 2000 May;6(5):1840-4.

PMID:10815906
Abstract

The present study was designed to analyze the expression of p53 and mdm2 in clear cell renal cell carcinoma with special emphasis on their association with tumor grade and clinical outcome. In particular, the value of individual protein overexpression as well as combined p53/mdm2 positivity was evaluated because both proteins are functionally connected, and their expression is controlled by an autoregulatory feedback loop. A cohort of 97 clear cell renal cell carcinomas was analyzed. The overexpression of mdm2 and p53 proteins was investigated on paraffin-embedded material by using monoclonal antibodies. Eighteen tumors showed mdm2 positivity, whereas 35 of the tumors overexpressed p53. Whereas p53 and mdm2 positivity correlated significantly (P = 0.00004), no correlation could be found between mdm2 protein overexpression and tumor stage, lymph node involvement, and presence of distant metastases. mdm2 positivity was found significantly more frequently in tumors of higher grade. In univariate analysis, there was a statistically significant correlation between p53 and mdm2 overexpression in the same tumor and poor survival (P = 0.00179). Multivariate analysis revealed that coincident mdm2/p53 overexpression, the presence of distant metastases, and tumor grade were independent predictors for tumor progression. Our results indicate that mdm2/p53 co-overexpression, nuclear grade, and preoperative presence of distant metastasis are independent predictors for poor survival.

摘要

本研究旨在分析p53和mdm2在透明细胞肾细胞癌中的表达情况,特别关注它们与肿瘤分级和临床结局的关联。具体而言,对单个蛋白过表达以及p53/mdm2联合阳性的价值进行了评估,因为这两种蛋白在功能上相互关联,且它们的表达受一个自动调节反馈环控制。对97例透明细胞肾细胞癌队列进行了分析。通过使用单克隆抗体在石蜡包埋材料上研究mdm2和p53蛋白的过表达情况。18例肿瘤显示mdm2阳性,而35例肿瘤p53过表达。虽然p53和mdm2阳性显著相关(P = 0.00004),但未发现mdm2蛋白过表达与肿瘤分期、淋巴结受累及远处转移的存在之间存在相关性。在高级别肿瘤中,mdm2阳性的发现频率显著更高。在单变量分析中,同一肿瘤中p53和mdm2过表达与较差的生存率之间存在统计学显著相关性(P = 0.00179)。多变量分析显示,mdm2/p53同时过表达、远处转移的存在以及肿瘤分级是肿瘤进展的独立预测因素。我们的结果表明,mdm2/p53共同过表达、核分级以及术前远处转移的存在是生存率差的独立预测因素。

相似文献

1
mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters.MDM2表达作为透明细胞肾细胞癌的预后指标:与p53过表达及临床病理参数的比较
Clin Cancer Res. 2000 May;6(5):1840-4.
2
The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.p53、MDM2和c-erb B-2癌蛋白、表皮生长因子受体及增殖标志物在膀胱癌预后中的作用
Pathol Res Pract. 1997;193(11-12):767-75. doi: 10.1016/S0344-0338(97)80055-6.
3
Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter.p53和MDM2在肾盂及输尿管移行细胞癌肿瘤增殖及预后判定中的作用
Int J Urol. 2000 Dec;7(12):457-63. doi: 10.1046/j.1442-2042.2000.00230.x.
4
p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.p53和mdm2作为上皮性卵巢癌患者的预后指标:一项多因素分析
Gynecol Oncol. 2005 Apr;97(1):46-52. doi: 10.1016/j.ygyno.2004.12.053.
5
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.细胞周期标志物p53、MDM2、p21和Ki-67在浅表性膀胱肿瘤复发中的预测价值
Clin Cancer Res. 1999 Dec;5(12):4079-84.
6
[Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].[人星形细胞瘤中P21 WAF1/CIP1的表达与P53、MDM2及细胞增殖指数的相关性]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Aug;23(4):341-5.
7
The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.血小板反应蛋白-1和p53在透明细胞肾细胞癌中的表达:其与血管生成、细胞增殖及癌症特异性生存的关系
J Urol. 2009 Nov;182(5):2144-9. doi: 10.1016/j.juro.2009.07.015. Epub 2009 Sep 15.
8
Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.联合 p53 和 MDM2 生物标志物分析显示,在接受根治性肾切除术的肾细胞癌患者中,与预后不良相关的表达模式具有独特性。
BJU Int. 2012 Apr;109(8):1250-7. doi: 10.1111/j.1464-410X.2011.10433.x. Epub 2011 Jul 14.
9
High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.Mdm2/p53共过表达在四肢软组织肉瘤中的高预后意义。
Oncogene. 1998 Mar 5;16(9):1183-5. doi: 10.1038/sj.onc.1201646.
10
P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.P53和MDM2过表达与接受根治性肾切除术的肾癌患者的五年生存率——伊朗经验
Asian Pac J Cancer Prev. 2015;16(12):5043-7. doi: 10.7314/apjcp.2015.16.12.5043.

引用本文的文献

1
Genetic Variations in Gene Contribute to Renal Cell Carcinoma Susceptibility: A Genotype-Phenotype Correlation Study.基因中的遗传变异与肾细胞癌易感性相关:一项基因型-表型相关性研究。
Cancers (Basel). 2025 Jan 8;17(2):177. doi: 10.3390/cancers17020177.
2
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.肾癌的生物标志物和治疗靶点:survivin(BIRC5)、XIAP、MCL-1、HIF1α、HIF2α、NRF2、MDM2、MDM4、p53、KRAS 和 AKT。
J Exp Clin Cancer Res. 2021 Aug 12;40(1):254. doi: 10.1186/s13046-021-02026-1.
3
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
阻断 MDM2 信号通路可通过抗原呈递机制增强基于 MDM2 靶向 T 细胞的抗肿瘤免疫治疗。
Cancer Immunol Immunother. 2021 Dec;70(12):3421-3434. doi: 10.1007/s00262-021-02940-5. Epub 2021 Apr 18.
4
Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.在源自卵巢和肾脏的晚期透明细胞癌的临床前模型中,鼠双微体 2 抑制剂的作用。
Cancer Sci. 2020 Oct;111(10):3824-3834. doi: 10.1111/cas.14583. Epub 2020 Aug 7.
5
Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors.Mdm2介导的pVHL的NEDDylation阻断抗血管生成因子的诱导。
Oncogene. 2020 Jul;39(29):5228-5239. doi: 10.1038/s41388-020-1359-4. Epub 2020 Jun 17.
6
Role of Autophagy in Renal Cancer.自噬在肾癌中的作用。
J Cancer. 2019 Jun 2;10(11):2501-2509. doi: 10.7150/jca.29285. eCollection 2019.
7
Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis.新型色氨酸衍生分子通过干扰 Mdm2 激活 p53 促进细胞凋亡。
Cell Cycle. 2018;17(15):1917-1930. doi: 10.1080/15384101.2018.1506664. Epub 2018 Sep 5.
8
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.SRSF2剪接因子表达降低抑制肾癌中的凋亡途径。
Int J Mol Sci. 2016 Sep 28;17(10):1598. doi: 10.3390/ijms17101598.
9
Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways.p53和HIF1α在人肾癌细胞凋亡中对mTOR和MDM2信号通路抑制的协同作用。
Drug Des Devel Ther. 2016 Feb 18;10:745-55. doi: 10.2147/DDDT.S88779. eCollection 2016.
10
Association of p53 rs1042522, MDM2 rs2279744, and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population.p53基因rs1042522、MDM2基因rs2279744和p21基因rs1801270多态性与中国人群视网膜母细胞瘤风险及侵袭的相关性
Sci Rep. 2015 Aug 20;5:13300. doi: 10.1038/srep13300.